InnoGene Sets Record Date for Extraordinary General Meeting on July 15, 2026

InnoGene announced the setting of July 15, 2026 as the record date to determine shareholders entitled to vote at the Extraordinary General Meeting.
The board resolution was passed on June 30, 2026, and the book closure period is not separately indicated due to the electronic securities system.
This record date setting is a routine procedure for the general meeting and does not involve any capital changes or financial impact.
[AI Summary]InnoGene's record date announcement is a routine administrative step for its general meeting, with no direct impact on shareholder value such as dilution or dividend changes. It is evaluated as a neutral event from an investment perspective.